Arrowhead Pharmaceuticals Stock Price on November 22, 2024
| ARWR Stock | USD 18.79 0.25 1.35% |
Below is the normalized historical share price chart for Arrowhead Pharmaceuticals extending back to December 16, 1993. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arrowhead Pharmaceuticals stands at 18.79, as last reported on the 26th of November, with the highest price reaching 19.84 and the lowest price hitting 18.73 during the day.
If you're considering investing in Arrowhead Stock, it is important to understand the factors that can impact its price. Arrowhead Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11% return per unit of risk over the last 3 months. Arrowhead Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Arrowhead Pharmaceuticals' Standard Deviation of 3.0, mean deviation of 2.18, and Risk Adjusted Performance of (0.09) to double-check the risk estimate we provide.
At this time, Arrowhead Pharmaceuticals' Total Stockholder Equity is relatively stable compared to the past year. As of 11/26/2024, Common Stock Total Equity is likely to grow to about 239.1 K, while Preferred Stock Total Equity is likely to drop 13.68. . As of 11/26/2024, Price To Sales Ratio is likely to drop to 10.24. In addition to that, Price Earnings Ratio is likely to drop to -16.96. Arrowhead Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date | 200 Day MA 24.5753 | 50 Day MA 19.8572 | Beta 0.934 |
Arrowhead |
Sharpe Ratio = -0.1094
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ARWR |
Estimated Market Risk
| 3.03 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.33 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Arrowhead Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arrowhead Pharmaceuticals by adding Arrowhead Pharmaceuticals to a well-diversified portfolio.
Price Book 6.9727 | Enterprise Value Ebitda (11.02) | Price Sales 118.8863 | Shares Float 110.5 M | Wall Street Target Price 47.2857 |
Related Headline
Wave Life Headline on 22nd of November 2024
SNDL Inc. announces corporate restructuring by investing.com
SNDL Inc. announces corporate restructuring
Arrowhead Pharmaceuticals Valuation on November 22, 2024
It is possible to determine the worth of Arrowhead Pharmaceuticals on a given historical date. On November 22, 2024 Arrowhead was worth 18.3 at the beginning of the trading date compared to the closed value of 18.54. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arrowhead Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Arrowhead Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arrowhead Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arrowhead Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 18.75 | 18.83 | 18.21 | 18.28 | 759,757 | |
11/22/2024 | 18.30 | 18.87 | 18.13 | 18.54 | 1,036,940 |
| 18.99 | 19.84 | 18.73 | 18.79 | 1,505,888 |
| Backtest Arrowhead Pharmaceuticals | | | Arrowhead Pharmaceuticals History | | | Arrowhead Pharmaceuticals Valuation | Previous | Next |
Arrowhead Pharmaceuticals Trading Date Momentum on November 22, 2024
| On November 25 2024 Arrowhead Pharmaceuticals was traded for 18.79 at the closing time. The top price for the day was 19.84 and the lowest listed price was 18.73 . The trading volume for the day was 1.5 M. The trading history from November 25, 2024 was a factor to the next trading day price gain. The overall trading delta against the next closing price was 1.35% . The overall trading delta against the current closing price is 2.43% . |
Arrowhead Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Arrowhead Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arrowhead Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arrowhead financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Arrowhead Pharmaceuticals Stock history
Arrowhead Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arrowhead is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arrowhead Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arrowhead Pharmaceuticals stock prices may prove useful in developing a viable investing in Arrowhead Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 122.8 M | 128.9 M | |
| Net Loss | -184.7 M | -175.5 M |
Arrowhead Pharmaceuticals Quarterly Net Working Capital |
|
Arrowhead Pharmaceuticals Stock Technical Analysis
Arrowhead Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Arrowhead Pharmaceuticals Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Arrowhead Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Arrowhead Pharmaceuticals November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Arrowhead Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arrowhead Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Arrowhead Pharmaceuticals stock market strength indicators, traders can identify Arrowhead Pharmaceuticals entry and exit signals to maximize returns
Arrowhead Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arrowhead Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Arrowhead Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arrowhead to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (0.85) | |||
| Treynor Ratio | (0.22) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.